Luoxin Pharmaceuticals Group Stock Co Ltd Financial Flexibility Index
Luoxin Pharmaceuticals Group Stock Co Ltd financial flexibility index. Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥98.10 Million (operating CF CN¥90.75 Million minus capex CN¥7.34 Million) represents 0% of total liabilities (CN¥2.46 Billion). See cash generation quality of Luoxin Pharmaceuticals Group Stock Co Lt to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2025)
Financial flexibility index of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2025. Historical Financial Flexibility Index trend for Luoxin Pharmaceuticals Group Stock Co Ltd across 15 annual periods. Check earnings quality score of Luoxin Pharmaceuticals Group Stock Co Lt to evaluate the quality of earnings relative to operating cash generation.
Luoxin Pharmaceuticals Group Stock Co Ltd Financial Flexibility Index by Year (2011–2025)
Luoxin Pharmaceuticals Group Stock Co Ltd financial flexibility index by year from 2011 to 2025. Year-by-year free cash flow to debt coverage for Luoxin Pharmaceuticals Group Stock Co Ltd. For the full cash flow conversion analysis, see 002793 cash generation efficiency.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | CN¥285.25 Million | CN¥253.07 Million | CN¥2.49 Billion | ▲ +875.6% |
| 2024 | -0.01x | CN¥-42.50 Million | CN¥-157.85 Million | CN¥2.88 Billion | ▼ -104.7% |
| 2023 | 0.31x | CN¥795.18 Million | CN¥552.79 Million | CN¥2.54 Billion | ▲ +301.6% |
| 2022 | -0.16x | CN¥-744.31 Million | CN¥-939.13 Million | CN¥4.80 Billion | ▼ -271.8% |
| 2021 | 0.09x | CN¥429.66 Million | CN¥120.63 Million | CN¥4.76 Billion | ▼ -7.3% |
| 2020 | 0.10x | CN¥328.36 Million | CN¥-32.40 Million | CN¥3.37 Billion | ▼ -51.1% |
| 2019 | 0.20x | CN¥696.91 Million | CN¥116.33 Million | CN¥3.50 Billion | ▼ -67.6% |
| 2018 | 0.61x | CN¥301.99 Million | CN¥114.12 Million | CN¥491.85 Million | ▼ -66.3% |
| 2017 | 1.82x | CN¥263.34 Million | CN¥102.27 Million | CN¥144.74 Million | ▲ +45.0% |
| 2016 | 1.25x | CN¥143.75 Million | CN¥72.74 Million | CN¥114.56 Million | ▲ +164.0% |
| 2015 | 0.48x | CN¥99.85 Million | CN¥58.12 Million | CN¥210.10 Million | ▼ -35.4% |
| 2014 | 0.74x | CN¥97.41 Million | CN¥41.83 Million | CN¥132.40 Million | ▼ -2.3% |
| 2013 | 0.75x | CN¥84.23 Million | CN¥64.75 Million | CN¥111.80 Million | ▲ +10.0% |
| 2012 | 0.69x | CN¥114.28 Million | CN¥33.31 Million | CN¥166.77 Million | ▲ +17.8% |
| 2011 | 0.58x | CN¥69.84 Million | CN¥46.53 Million | CN¥120.07 Million | — |